Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000756362 | SCV000884152 | uncertain significance | not provided | 2018-03-20 | criteria provided, single submitter | clinical testing | This variant affects the MT-TE gene, which encodes the mitochondrial tRNA for glutamic acid, and has not been reported in the medical literature, is not listed in gene-specific variant databases, nor has it been previously identified in our laboratory. It is also absent from population databases such as MITOMAP. This variant disrupts a weakly conserved nucleotide, and several primate species, including the gorilla, gibbon, and rhesus monkey, have a thymine at this position, suggesting this variant is evolutionary tolerated. However, based on the available information, the clinical significance of the m.14701C>T variant cannot be determined with certainty. Pathogenic variants in MT-TE have been associated with mitochondrial disorders. |
Centre for Mendelian Genomics, |
RCV001198151 | SCV001368994 | uncertain significance | See cases | 2019-09-24 | criteria provided, single submitter | clinical testing | This variant was classified as: Uncertain significance. The available evidence on this variant's pathogenicity is insufficient or conflicting. The following ACMG criteria were applied in classifying this variant: PM2. |
Department of Clinical Genetics, |
RCV001523793 | SCV001450724 | likely pathogenic | Mitochondrial myopathy with reversible cytochrome C oxidase deficiency | 2020-12-01 | no assertion criteria provided | clinical testing |